Cynosure continues to expand its cellulite reduction devices with additional regulatory clearances. The minimally invasive Cellulaze Cellulite Laser Workstation has received clearance from Australia’s Therapeutic Goods Association. The noninvasive SmoothShapes XV has received clearance from the Taiwan Food and Drug Administration. “Australia and Asia are important and attractive markets for Cynosure as we focus on expanding the international reach of our newest products, particularly our cellulite platform,” said Michael Davin, Cynosure president and CEO, in a company statement.
Cynosure Receives International Approvals
Jul 1st, 2011